cladribine has been researched along with Granuloma, Plasma Cell, Orbital in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antić, B; Jovandić, S; Knezević-Usaj, S; Magić, Z; Perić, P; Radić-Tasić, O; Radovinović-Tasić, S; Sekulović, L; Tarabar, O; Tukić, L; Vasić-Vilić, J | 1 |
1 other study(ies) available for cladribine and Granuloma, Plasma Cell, Orbital
| Article | Year |
|---|---|
Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
Topics: Adult; Antineoplastic Agents; Biomarkers; Cladribine; Diabetes Insipidus; Dose-Response Relationship, Drug; Erdheim-Chester Disease; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Male; Mutation; Orbital Pseudotumor; Proto-Oncogene Proteins B-raf; Treatment Outcome | 2016 |